Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market to Perceive Substantial Growth by the End 2025
Attention deficit hyperactivity disorder is a disorder of brain, formerly known as attention deficit disorder. It is one of the most common mental disorders affecting children as well as adults. According to an estimation by the American Psychiatric Association, 2.5% of adults and 5% of children suffer from attention deficit hyperactivity disorder in the U.S. Among the children, the disorder is more common in boys than in girls.
Attention deficit hyperactivity disorder is a condition where the patient has trouble in sitting still, focusing on tasks, and paying attention. The patient acts without thinking. This disorder can be diagnosed between the age of 6 and 12 years. The disorder is diagnosed by gathering information from teachers, parents, and others by performing a medical evaluation (including hearing and vision screening) and filling out checklists. No specific cause of the disorder is known.
Increase in the number of pre-term births of babies is a driving factor for the attention deficit hyperactivity disorder market. According to the University of Maryland Medical Center (UMMC), currently, 20% of the prematurely born babies develop this disorder. Increasing inclination of pregnant women toward toxins such as alcohol, cigarette, and drugs leads to children born with the attention deficit hyperactivity disorder. Complementary and alternative therapies such as special diets, vitamins, minerals, and herbs may restrain the attention deficit hyperactivity disorder market during the forecast period.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32177
The attention deficit hyperactivity disorder market can be segmented on the basis of symptom type, treatment type, end-user, and region. Based on symptom type, the market can be classified into impulsivity (acting without thinking), hyperactivity (trouble in sitting still), and inattention (trouble in focusing). Based on treatment type, the market can be segmented into psychotherapy, medication, combination of treatments, and others.
The psychotherapy segment can be sub-divided into family & marital therapy and behavioral therapy. The medication segment can further be classified into stimulants and non-stimulants. The medication segment is anticipated to hold a large market share during the forecast period, due to technological advancements and increasing R&D activities. Psychotherapy and combination of treatments segments are expected to expand at a moderate rate during the forecast period, owing to increasing awareness about attention deficit hyperactivity disorder among the people and technological advancements. Based on end user, the market can be segmented into pediatric clinics, psychological centers, hospitals and others.
Request for Analysis of COVID-19 Impact on Attention Deficit Hyperactivity Disorder Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=32177
Geographically, the global attention deficit hyperactivity disorder market can be divided into Asia Pacific, Latin America, Middle East & Africa, North America, and Europe. North America is expected to hold a leading market share from 2017 to 2025, owing to high usage of cigarettes, alcohol, and drugs during pregnancy in the region. According to the American Psychiatric Association, in the U.S., approximately 1 in 20 children is affected by attention deficit hyperactivity disorder. In terms of market share, Europe is projected to follow North America during the forecast period, due to high prevalence of attention deficit hyperactivity disorder in the region. For instance, the prevalence of attention deficit hyperactivity disorder is high in Ukraine, due to psychosocial dislocation and environmental adversity associated with the Chernobyl disaster. The market in Asia Pacific, Middle East & Africa, and Latin America is anticipated to expand at a significant rate during the forecast period, due to growing population of baby boomers and high rate of nutritional deficiencies and imbalances among children in developing countries in these regions.
Pre Book Attention Deficit Hyperactivity Disorder Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=32177<ype=S
Key players operating in the global attention deficit hyperactivity disorder market are Janssen Global Services, LLC, Cingulate Therapeutics, LLC, Shire, Eli Lilly and Company, Purdue Pharma L.P., GlaxoSmithKline plc, and Novartis AG.
More Trending Reports by Transparency Market Research –
Cell Separation Technology Market: https://www.prnewswire.com/news-releases/cell-separation-technology-market-to-clock-cagr-of–12-from-2019-to-2027-stem-cell-research-to-account-for-colossal-revenue-streams-notes-tmr-301086765.html
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453